Authors
Latest:
The Holy Grail of Product DevelopmentDefining, evaluating, and utilizing the Target Product Profile.
Latest:
The Future of Media and Social Influence MarketingCommunications planning in 2009 and beyond will include online, offline, mobile, out-of-home, point-of-sale, gaming consoles, and more-even your car's navigation system will be tied to Google! Perhaps most importantly, communications planning will begin to include social influence marketing.
Latest:
Putting Predictive Market Research to the TestThere's a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?
Latest:
Top 10 Detailing PitfallsCompetition for physicians' time has become so intense that some medical groups have severely restricted or banned reps altogether. Part of that strained relationship can be traced back to some of the sales techniques used by aggressive pharma salespeople. Physicians have become wary of being "sold" and often do not trust the information reps provide. Many doctors no longer feel that sales reps help provide better care for patients. Rather, physicians often come away feeling as though they just had an encounter with a used car dealer. To improve their relationships with medical professionals, pharma sales reps should avoid ten
Latest:
Wyeth V. Levine: An Attorneys' PerspectiveLawyers from Duane Morris LLP offer their take on the Supreme Court's groundshaking preemption decision
Latest:
Part 3: How to Enforce Post-Employment RestrictionsCourts are often hesitant to enforce such restrictions, so employers should take certain steps prior to and in the process of filing such a lawsuit.
Latest:
How Do You Solve a Problem Like Manufacturing?Outsourcing saves money-except when it doesn't. Here's how to decide what to do.
Latest:
Goodbye, Willy LomanThe days of pharma sales reps going office-to-office with samples and brochures are done. These days, they need to turn their attention to payers, pharmacists, and consumers
Latest:
Education Trumps RegulationNew research points to the power of a highly educated sales force, supporting the case for a voluntary educational standard
Latest:
Blueprint for ExcellenceIn a time of slow growth, true innovators forge new relationships with core customers
Latest:
A New Game Plan for Pharma HRNew dynamics are forcing the industry's human resource departments to rethink their operational game plans. The drivers-consolidation, globalization, scientific advances, public policy, and competition-have pushed HR leaders into new territory to address business needs.
Latest:
Where Caremark Meets Park: A New Era of Regulatory Compliance and Criminal LiabilityThe Caremark and Park doctrines require directors and managers of life sciences companies to address regulatory compliance proactively and vigorously.
Latest:
Earning the Public Trust—and Keeping ItThe industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?
Latest:
Part 3: How to Enforce Post-Employment RestrictionsCourts are often hesitant to enforce such restrictions, so employers should take certain steps prior to and in the process of filing such a lawsuit.
Latest:
How Not to Handle RebatesIn these cost cutting times, no drugmaker can afford to keep shoveling money down the Rebate Black Hole. Here's how to optimize your ROI and push back against the growing pressure of third-party rebates
Latest:
Magic MoleculesPharm Exec's Pipeline Report is packed with 25 of the year's most eye-catching experimental drugs. What's their secret? No smoke or mirrors-just innovative science, therapeutic value, and good business sense.
Latest:
Site Activation: The Key to More Efficient Clinical TrialsA new study of hundreds of thousands of clinical trial records reveals that the overall length of a trial is directly related to how long it takes to activate the study sites - and that most companies are wasting precious weeks and even months in activation. Here's how to improve your performance.
Latest:
Wyeth V. Levine: An Attorneys' PerspectiveLawyers from Duane Morris LLP offer their take on the Supreme Court's groundshaking preemption decision
Latest:
Crisis Preparedness in an Always-On Digital WorldThe first 120 minutes of a crisis can determine the public’s perception of an organization. And in today’s digital world, companies are more at risk than ever to viral attacks from unexpected sources.
Latest:
The Rise and Fall of Pharma ReputationsAs a reputation driver, ethical behavior has increased steadily in importance over the last three years.
